Chromosome 4p16.3 variant modify bladder cancer risk in a Chinese population

Genetic variation in PSCA and bladder cancer susceptibility in a Chinese population

(2010) S. Wang et al.   CARCINOGENESIS

Fibroblast Growth Factor Receptor 3 Mutation Analysis on Voided Urine for Surveillance of Patients with Low-Grade Non-Muscle-Invasive Bladder Cancer

(2010) T. C. M. Zuiverloon et al.   CLINICAL CANCER RESEARCH

Bladder Cancer Working Group Report

(2010) Y. Kakehi et al.   JAPANESE JOURNAL OF CLINICAL ONCOLOGY

A sequence variant at 4p16.3 confers susceptibility to urinary bladder cancer

(2010) Lambertus A Kiemeney et al.   NATURE GENETICS

A novel XPF −357A>C polymorphism predicts risk and recurrence of bladder cancer

(2010) M Wang et al.   ONCOGENE

Common genetic variants on 8q24 contribute to susceptibility to bladder cancer in a Chinese population

(2009) Meilin Wang et al.   CARCINOGENESIS

Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer

(2009) Xifeng Wu et al.   NATURE GENETICS

Genomewide Association Studies and Human Disease

(2009) John Hardy et al.   NEW ENGLAND JOURNAL OF MEDICINE

Prediction of Progression of Non–Muscle-Invasive Bladder Cancer by WHO 1973 and 2004 Grading and by FGFR3 Mutation Status: A Prospective Study

(2008) Maximilian Burger et al.   EUROPEAN UROLOGY

Sequence variant on 8q24 confers susceptibility to urinary bladder cancer

(2008) Lambertus A Kiemeney et al.   NATURE GENETICS